LI-RADS分类与组织病理学特征同孤立性切除肝细胞癌患者生存期的关联
这项回顾性研究纳入三家机构2008年1月至2019年12月间360例孤立性切除肝细胞癌患者,术前接受增强CT和/或MRI检查,由三名独立阅片者评估LI-RADS v2018分类与特征。结果显示LR-M类别及至少一个非靶样特征与复发和死亡风险升高独立相关,且独立于组织病理学特征。
要点
- LR-M类别在CT和MRI上均与复发和死亡风险升高独立相关,且独立于组织病理学特征。
- 存在至少一个非靶样特征与复发和死亡风险升高独立相关,且独立于组织病理学特征。
- 倾向性评分匹配后,CT或MRI上至少一个非靶样特征仍与复发相关。
核心结论
- 在孤立性切除肝细胞癌患者中,LR-M类别和非靶样特征与生存期呈负相关,且独立于组织病理学特征。
研究设计与样本
- 回顾性研究,纳入三家机构2008年1月至2019年12月间360例孤立性切除肝细胞癌患者,术前接受增强CT和/或MRI检查,由三名独立阅片者评估LI-RADS v2018分类与特征。
诊断标准与关键数值
- CT上LR-M类别与复发风险升高相关(HR=1.83,95%CI:1.26,2.66,P=.001),与死亡风险升高相关(HR=2.47,95%CI:1.72,3.55,P<.001),独立于组织病理学特征。
- MRI上LR-M类别与复发风险升高相关(HR=2.22,95%CI:1.56,3.16,P<.001),与死亡风险升高相关(HR=1.80,95%CI:1.32,2.46,P<.001),独立于组织病理学特征。
- CT上存在至少一个非靶样特征与复发风险升高相关(HR=1.80,95%CI:1.36,2.38,P<.001),与死亡风险升高相关(HR=1.51,95%CI:1.10,2.07,P<.010),独立于组织病理学特征。
- MRI上存在至少一个非靶样特征与复发风险升高相关(HR=1.93,95%CI:1.81,2.06,P<.001),独立于组织病理学特征。
- 匹配样本中,CT上存在至少一个非靶样特征与复发相关(HR=2.06,95%CI:1.15,3.66,P=.02),MRI上存在至少一个非靶样特征与复发相关(HR=1.79,95%CI:1.01,3.20,P=.048)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Both Liver Imaging Reporting and Data System (LI-RADS) and histopathologic features provide prognostic information in patients with hepatocellular carcinoma (HCC), but whether LI-RADS is independently associated with survival is uncertain. Purpose To assess the association of LI-RADS categories and features with survival outcomes in patients with solitary resected HCC. Materials and Methods This retrospective study included patients with solitary resected HCC from three institutions examined with preoperative contrast-enhanced CT and/or MRI between January 2008 and December 2019. Three independent readers evaluated the LI-RADS version 2018 categories and features. Histopathologic features including World Health Organization tumor grade, microvascular and macrovascular invasion, satellite nodules, and tumor capsule were recorded. Overall survival and disease-free survival were assessed with Cox regression models. Marginal effects of nontargetoid features on survival were estimated using propensity score matching. Results A total of 360 patients (median age, 64 years [IQR, 56-70 years]; 280 male patients) were included. At CT and MRI, the LI-RADS LR-M category was associated with increased risk of recurrence (CT: hazard ratio [HR] = 1.83 [95% CI: 1.26, 2.66], P = .001; MRI: HR = 2.22 [95% CI: 1.56, 3.16], P < .001) and death (CT: HR = 2.47 [95% CI: 1.72, 3.55], P < .001; MRI: HR = 1.80 [95% CI: 1.32, 2.46], P < .001) independently of histopathologic features. The presence of at least one nontargetoid feature was associated with an increased risk of recurrence (CT: HR = 1.80 [95% CI: 1.36, 2.38], P < .001; MRI: HR = 1.93 [95% CI: 1.81, 2.06], P < .001) and death (CT: HR = 1.51 [95% CI: 1.10, 2.07], P < .010) independently of histopathologic features. In matched samples, recurrence was associated with the presence of at least one nontargetoid feature at CT (HR = 2.06 [95% CI: 1.15, 3.66]; P = .02) or MRI (HR = 1.79 [95% CI: 1.01, 3.20]; P = .048). Conclusion In patients with solitary resected HCC, LR-M category and nontargetoid features were negatively associated with survival independently of histopathologic characteristics. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Kartalis and Grigoriadis in this issue.
引用
- Cannella R, Matteini F, Dioguardi Burgio M, et al. Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma. Radiology. 2024. PMID: 38411519. doi:10.1148/radiol.231160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。